Literature DB >> 6843667

Gene deletions in patients with haemophilia B and anti-factor IX antibodies.

F Giannelli, K H Choo, D J Rees, Y Boyd, C R Rizza, G G Brownlee.   

Abstract

Christmas disease, or haemophilia B, is an inherited X-linked haemorrhagic disease which at present occurs in 798 known cases in the United Kingdom, corresponding to a frequency of about 1 in 30,000 males. Patients are deficient in the intrinsic clotting factor IX and are treated by replacement of this protein prepared from pooled plasma obtained from normal individuals. Occasionally treatment is complicated by the appearance of specific anti-factor IX antibodies. It seemed to us that this might be due to the absence of 'self' factor IX causing the immune system to regard the infused normal factor IX as foreign. The absence of all or part of the factor IX gene was an obvious possible reason for this, which we have now tested using our previously isolated gene probe. We have found four patients with gross gene defects.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6843667     DOI: 10.1038/303181a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  59 in total

1.  A new strategy for the genetic counselling of diseases of marked mutational heterogeneity: haemophilia B as a model.

Authors:  F Giannelli; S Saad; A J Montandon; D R Bentley; P M Green
Journal:  J Med Genet       Date:  1992-09       Impact factor: 6.318

Review 2.  Alport syndrome, basement membranes and collagen.

Authors:  C E Kashtan; M M Kleppel; R J Butkowski; A F Michael; A J Fish
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

3.  Hemophilia B (factor IXSeattle 2) due to a single nucleotide deletion in the gene for factor IX.

Authors:  B G Schach; S Yoshitake; E W Davie
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

4.  From caveman companion to medical innovator: genomic insights into the origin and evolution of domestic dogs.

Authors:  Heidi G Parker; Samuel F Gilbert
Journal:  Adv Genomics Genet       Date:  2015-06-12

5.  Molecular studies of haemophilia B in Sweden. Identification of patients with total deletion of the factor IX gene and without inhibitory antibodies.

Authors:  C Wadelius; M Blombäck; U Pettersson
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

6.  An intragenic deletion of the factor IX gene in a family with hemophilia B.

Authors:  S H Chen; S Yoshitake; P F Chance; G L Bray; A R Thompson; C R Scott; K Kurachi
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

7.  Assessment of the F9 genotype-specific FIX inhibitor risks and characterisation of 10 novel severe F9 defects in the first molecular series of Argentinian patients with haemophilia B.

Authors:  Claudia Pamela Radic; Liliana Carmen Rossetti; Miguel Martín Abelleyro; Miguel Candela; Raúl Pérez Bianco; Miguel de Tezanos Pinto; Irene Beatriz Larripa; Anne Goodeve; Carlos Daniel De Brasi
Journal:  Thromb Haemost       Date:  2012-10-23       Impact factor: 5.249

8.  Gene deletion in an Italian haemophilia B subject.

Authors:  F Bernardi; L del Senno; R Barbieri; D Buzzoni; R Gambari; G Marchetti; F Conconi; F Panicucci; M Positano; S Pitruzzello
Journal:  J Med Genet       Date:  1985-08       Impact factor: 6.318

9.  Carrier detection of Hemophilia B by using a restriction site polymorphism associated with the coagulation Factor IX gene.

Authors:  L Grunebaum; J P Cazenave; G Camerino; C Kloepfer; J L Mandel; P Tolstoshev; M Jaye; H De la Salle; J P Lecocq
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

10.  The rates and patterns of deletions in the human factor IX gene.

Authors:  R P Ketterling; E L Vielhaber; T J Lind; E C Thorland; S S Sommer
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.